Reynders Mcveigh Capital Management Has Raised Stake in Gilead Sciences (GILD) by $1.41 Million as Valuation Rose; Pl Capital Advisors Trimmed Its Peoples Bancorp (PEBO) Holding by $7.83 Million as Share Value Rose

April 26, 2018 - By Hazel Jackson

Peoples Bancorp Inc. (NASDAQ:PEBO) Logo

Reynders Mcveigh Capital Management Llc increased its stake in Gilead Sciences Inc (GILD) by 41.01% based on its latest 2017Q4 regulatory filing with the SEC. Reynders Mcveigh Capital Management Llc bought 19,800 shares as the company’s stock rose 1.93% while stock markets declined. The institutional investor held 68,079 shares of the health care company at the end of 2017Q4, valued at $4.88M, up from 48,279 at the end of the previous reported quarter. Reynders Mcveigh Capital Management Llc who had been investing in Gilead Sciences Inc for a number of months, seems to be bullish on the $95.51B market cap company. The stock increased 0.73% or $0.53 during the last trading session, reaching $73.25. About 6.34 million shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has risen 9.79% since April 26, 2017 and is uptrending. It has underperformed by 1.76% the S&P500.

Pl Capital Advisors Llc decreased its stake in Peoples Bancorp (PEBO) by 43.32% based on its latest 2017Q4 regulatory filing with the SEC. Pl Capital Advisors Llc sold 244,835 shares as the company’s stock rose 5.41% while stock markets declined. The institutional investor held 320,344 shares of the major banks company at the end of 2017Q4, valued at $10.45M, down from 565,179 at the end of the previous reported quarter. Pl Capital Advisors Llc who had been investing in Peoples Bancorp for a number of months, seems to be less bullish one the $716.51 million market cap company. The stock decreased 1.33% or $0.5 during the last trading session, reaching $37.11. About 27,739 shares traded. Peoples Bancorp Inc. (NASDAQ:PEBO) has risen 13.90% since April 26, 2017 and is uptrending. It has outperformed by 2.35% the S&P500.

Since December 4, 2017, it had 1 insider buy, and 1 insider sale for $32,667 activity. BROUGHTON GEORGE W also sold $35,264 worth of Peoples Bancorp Inc. (NASDAQ:PEBO) shares.

Investors sentiment decreased to 0.98 in Q4 2017. Its down 0.24, from 1.22 in 2017Q3. It fall, as 8 investors sold PEBO shares while 36 reduced holdings. 10 funds opened positions while 33 raised stakes. 10.43 million shares or 0.74% more from 10.36 million shares in 2017Q3 were reported. Barclays Public Limited holds 0% or 2,934 shares in its portfolio. Parametric Port Associates Limited Liability reported 0% of its portfolio in Peoples Bancorp Inc. (NASDAQ:PEBO). Rhumbline Advisers holds 16,482 shares or 0% of its portfolio. New York State Teachers Retirement Sys owns 1,400 shares. Ubs Asset Americas Inc invested 0% of its portfolio in Peoples Bancorp Inc. (NASDAQ:PEBO). 20,595 are held by Duncker Streett. California Employees Retirement Systems holds 0% or 44,093 shares. Amer Gru Inc Inc holds 11,064 shares. Pnc Svcs Inc invested 0% of its portfolio in Peoples Bancorp Inc. (NASDAQ:PEBO). Alliancebernstein Ltd Partnership owns 17,220 shares or 0% of their US portfolio. Bancorporation Of Montreal Can accumulated 28,819 shares or 0% of the stock. Foundry Prtnrs Limited Company reported 219,010 shares or 0.3% of all its holdings. Buckingham Capital reported 7,708 shares stake. Jpmorgan Chase & has invested 0% in Peoples Bancorp Inc. (NASDAQ:PEBO). Huntington Savings Bank holds 15,966 shares or 0.01% of its portfolio.

Among 7 analysts covering Peoples Bancorp Inc (NASDAQ:PEBO), 0 have Buy rating, 0 Sell and 7 Hold. Therefore 0 are positive. Peoples Bancorp Inc had 15 analyst reports since July 28, 2015 according to SRatingsIntel. The rating was downgraded by Raymond James to “Outperform” on Friday, October 30. The rating was downgraded by Raymond James to “Mkt Perform” on Friday, December 16. Keefe Bruyette & Woods downgraded the stock to “Market Perform” rating in Friday, October 30 report. The stock of Peoples Bancorp Inc. (NASDAQ:PEBO) earned “Hold” rating by Boenning & Scattergood on Wednesday, July 26. On Thursday, December 21 the stock rating was maintained by Keefe Bruyette & Woods with “Hold”. The firm earned “Hold” rating on Tuesday, October 3 by Keefe Bruyette & Woods. The firm has “Market Perform” rating given on Monday, March 7 by Wood. Keefe Bruyette & Woods maintained the stock with “Hold” rating in Tuesday, April 24 report. Hovde Group maintained the stock with “Hold” rating in Tuesday, April 24 report. Sandler O’Neill maintained it with “Hold” rating and $37.0 target in Tuesday, January 23 report.

Investors sentiment decreased to 0.8 in Q4 2017. Its down 0.23, from 1.03 in 2017Q3. It worsened, as 95 investors sold GILD shares while 545 reduced holdings. 104 funds opened positions while 411 raised stakes. 972.68 million shares or 1.57% more from 957.62 million shares in 2017Q3 were reported. 43,246 are owned by Wright Invsts Serv. Maryland-based Price T Rowe Assocs Md has invested 0.2% in Gilead Sciences, Inc. (NASDAQ:GILD). Twin Capital Mngmt reported 97,720 shares. The Ohio-based Diamond Hill Mgmt Incorporated has invested 0.02% in Gilead Sciences, Inc. (NASDAQ:GILD). Parsec Mgmt Inc holds 91,506 shares or 0.44% of its portfolio. Flossbach Von Storch Ag has 3,770 shares. Kidder Stephen W reported 15,727 shares stake. Artemis Invest Llp holds 101,939 shares or 0.12% of its portfolio. Nuwave Inv Management Ltd Liability has invested 0.01% in Gilead Sciences, Inc. (NASDAQ:GILD). Harvey Cap Inc accumulated 96,100 shares or 2.49% of the stock. Amica Retiree Tru owns 8,305 shares or 0.45% of their US portfolio. Greylin Inv Mangement stated it has 0.76% in Gilead Sciences, Inc. (NASDAQ:GILD). Pillar Pacific Capital Management Limited Liability Co has invested 0.91% in Gilead Sciences, Inc. (NASDAQ:GILD). Eagle Glob Advisors Limited Liability holds 62,887 shares. Jupiter Asset holds 124,197 shares or 0.26% of its portfolio.

Since January 2, 2018, it had 0 buys, and 19 sales for $40.38 million activity. Another trade for 5,833 shares valued at $430,130 was made by Cogan John Francis on Friday, April 20. Alton Gregg H sold 15,000 shares worth $1.11 million. MARTIN JOHN C sold $4.18 million worth of Gilead Sciences, Inc. (NASDAQ:GILD) on Thursday, February 1. $401,566 worth of stock was sold by Washington Robin L on Wednesday, February 21. WILSON GAYLE E sold $4.68M worth of stock or 60,000 shares.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 21 have Buy rating, 0 Sell and 9 Hold. Therefore 70% are positive. Gilead Sciences had 126 analyst reports since July 29, 2015 according to SRatingsIntel. On Friday, April 29 the stock rating was maintained by UBS with “Buy”. Jefferies maintained the stock with “Buy” rating in Monday, June 12 report. The firm earned “Buy” rating on Wednesday, October 28 by Maxim Group. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Buy” rating by William Blair on Thursday, August 31. As per Wednesday, February 3, the company rating was maintained by Oppenheimer. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Market Perform” rating by Wells Fargo on Friday, December 4. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Buy” rating by Robert W. Baird on Friday, September 15. The rating was maintained by Needham with “Hold” on Tuesday, October 3. The rating was downgraded by Morgan Stanley on Friday, October 2 to “Equal-Weight”. On Monday, September 12 the stock rating was initiated by Berenberg with “Buy”.

Gilead Sciences, Inc. (NASDAQ:GILD) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>